FI971013A0 - Menetelmä kollageenin indusoiman verihiutaleaggregaation modifioidun inhibiittorin, pallidipiinin tuottamiseksi - Google Patents

Menetelmä kollageenin indusoiman verihiutaleaggregaation modifioidun inhibiittorin, pallidipiinin tuottamiseksi

Info

Publication number
FI971013A0
FI971013A0 FI971013A FI971013A FI971013A0 FI 971013 A0 FI971013 A0 FI 971013A0 FI 971013 A FI971013 A FI 971013A FI 971013 A FI971013 A FI 971013A FI 971013 A0 FI971013 A0 FI 971013A0
Authority
FI
Finland
Prior art keywords
pallidipine
producing
platelet aggregation
modified collagen
induced inhibitor
Prior art date
Application number
FI971013A
Other languages
English (en)
Swedish (sv)
Other versions
FI971013A (fi
Inventor
Christiane Noeske-Jungblut
Andreas Becker
Bernard Haendler
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of FI971013A0 publication Critical patent/FI971013A0/fi
Publication of FI971013A publication Critical patent/FI971013A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI971013A 1994-09-12 1997-03-11 Menetelmä kollageenin indusoiman verihiutaleaggregaation modifioidun inhibiittorin, pallidipiinin tuottamiseksi FI971013A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94250224 1994-09-12
PCT/EP1995/003573 WO1996008563A1 (en) 1994-09-12 1995-09-11 Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin

Publications (2)

Publication Number Publication Date
FI971013A0 true FI971013A0 (fi) 1997-03-11
FI971013A FI971013A (fi) 1997-03-11

Family

ID=8217517

Family Applications (1)

Application Number Title Priority Date Filing Date
FI971013A FI971013A (fi) 1994-09-12 1997-03-11 Menetelmä kollageenin indusoiman verihiutaleaggregaation modifioidun inhibiittorin, pallidipiinin tuottamiseksi

Country Status (22)

Country Link
US (1) US5882887A (fi)
EP (1) EP0781334A1 (fi)
JP (1) JPH10505502A (fi)
CN (1) CN1075836C (fi)
AU (1) AU701643B2 (fi)
BG (1) BG63276B1 (fi)
BR (1) BR9508910A (fi)
CA (1) CA2199719A1 (fi)
CZ (1) CZ76297A3 (fi)
FI (1) FI971013A (fi)
HU (1) HU222398B1 (fi)
IL (1) IL115272A0 (fi)
MX (1) MX9701720A (fi)
NO (1) NO971110L (fi)
NZ (1) NZ293261A (fi)
PL (1) PL184617B1 (fi)
RO (1) RO117971B1 (fi)
RU (1) RU2186110C2 (fi)
SI (1) SI9520093A (fi)
SK (1) SK29297A3 (fi)
WO (1) WO1996008563A1 (fi)
ZA (1) ZA957649B (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200102729T2 (tr) * 1999-03-18 2002-04-22 Merck Patent Gmbh Platelet yapışmasını bloke etme amaçlı protein
AU2005321315A1 (en) * 2004-12-28 2006-07-06 Ares Trading S.A. Compositions and methods for treating schizophrenia and related disorders
US20110034396A1 (en) * 2005-09-28 2011-02-10 Biovascular, Inc. Methods and compositions for inhibiting cell migration and treatment of inflammatory conditions
US7691839B2 (en) * 2005-09-28 2010-04-06 Biovascular, Inc. Methods and compositions for blocking platelet and cell adhesion, cell migration and inflammation
TWI391143B (zh) * 2005-11-04 2013-04-01 Otsuka Pharma Co Ltd 血小板凝集抑制劑組成物
WO2012172427A2 (en) * 2011-06-14 2012-12-20 National Taiwan University Peptide compounds for inhibition of platelet aggregation
FR2979346B1 (fr) 2011-08-23 2013-09-27 Univ Joseph Fourier Nanocorps anti-vcam-1
KR102063195B1 (ko) 2012-02-07 2020-01-07 글로벌 바이오 테라퓨틱스, 인크. 핵산 전달의 구획화된 방법 및 이의 조성물 및 용도
CN104837865B (zh) 2012-09-07 2019-09-24 国立健康与医学研究所 衍生自髓样细胞触发受体-1(trem-1)trem-样转录物1(tlt-1)的抑制肽及其用途
EA035829B1 (ru) 2013-08-08 2020-08-18 Глобал Био Терапьютикс, Инк. Зажимное устройство для минимального захвата и его использование
FR3058143B1 (fr) 2016-10-27 2021-03-12 Univ Grenoble Alpes Nanocorps anti-tau
CN118139655A (zh) 2021-08-13 2024-06-04 特里奥万斯控股公司 皮肤替代组合物及其产生和使用方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03503596A (ja) * 1987-06-24 1991-08-15 ノボ・ノルディスク　エー／エス 蛋白質若しくはポリペプチドの調製方法、該ポリペプチドをコードするｄｎａ配列、該ｄｎａ配列およびポリペプチドを有する微生物および該ポリペプチドの薬学的製剤としての利用
WO1993005150A1 (en) * 1991-09-05 1993-03-18 Schering Aktiengesellschaft Collagen-induced platelet aggregation inhibitor
US5756454A (en) * 1991-09-05 1998-05-26 Schering Aktiengesellschaft Collagen-induced platelet aggregation inhibitor
US5705362A (en) * 1992-05-25 1998-01-06 Gist-Brocades, N.V. Modified signal sequences

Also Published As

Publication number Publication date
BG101226A (en) 1998-10-30
AU3565795A (en) 1996-03-29
CN1159828A (zh) 1997-09-17
SK29297A3 (en) 1997-10-08
US5882887A (en) 1999-03-16
CA2199719A1 (en) 1996-03-21
BR9508910A (pt) 1997-10-28
HU222398B1 (hu) 2003-06-28
EP0781334A1 (en) 1997-07-02
NO971110L (no) 1997-05-07
MX9701720A (es) 1997-06-28
BG63276B1 (bg) 2001-08-31
JPH10505502A (ja) 1998-06-02
SI9520093A (en) 1997-08-31
CZ76297A3 (cs) 1998-01-14
ZA957649B (en) 1996-04-15
AU701643B2 (en) 1999-02-04
RU2186110C2 (ru) 2002-07-27
CN1075836C (zh) 2001-12-05
NZ293261A (en) 1998-11-25
PL184617B1 (pl) 2002-11-29
FI971013A (fi) 1997-03-11
RO117971B1 (ro) 2002-11-29
PL319078A1 (en) 1997-07-21
WO1996008563A1 (en) 1996-03-21
NO971110D0 (no) 1997-03-11
HUT76972A (hu) 1998-01-28
IL115272A0 (en) 1995-12-31

Similar Documents

Publication Publication Date Title
NO953282L (no) Fremgangsmåte for bedring av produktiviteten hos en brönn
ITMI951824A0 (it) Metodo per generare visualizzazioni m-mode anatomiche
DE69531313D1 (de) Regeneration einer Kryopumpe
KR19980701688A (ko) 흡수성 수지의 제조방법
IS1790B (is) Nýir hemlar á samsöfnun blóðflagna
NO961962D0 (no) Fremgangsmåte for bestemmelse av borebetingelser, omfattende en boremodell
NO954126D0 (no) Fremgangsmåte for frakturering av en undergrunnsformasjon
FI940939A0 (fi) Menetelmä pakettimuotoisen datayhteyden reitin vaihtamiseksi
FI971013A0 (fi) Menetelmä kollageenin indusoiman verihiutaleaggregaation modifioidun inhibiittorin, pallidipiinin tuottamiseksi
FI98770C (fi) Hierarkkinen synkronointimenetelmä
IT1274821B (it) Metodo di incarto per la formazione di pacchetti.
BR9405330A (pt) Processo para alterar a permeabilidade de uma formação subterrânea
FI95978C (fi) Hierarkkinen synkronointimenetelmä
ID21998A (id) Proses untuk pembuatan secara kontinyu senyawa alkil 5-formilvalerat
FI940980A (fi) Hierarkkinen synkronointimenetelmä
FI972180A (fi) Menetelmä piidioksidia sisältävän tulenkestävän massan valmistamiseksi
IT1270841B (it) Metodo per produrre formilimidazoli
FI940926A0 (fi) Hierarkkinen synkronointimenetelmä
EP1142785A4 (en) METHOD FOR PRODUCING LIQUID BAGS
FR2766746B1 (fr) Fraise pour percer et fileter par interpolation
KR970703418A (ko) 트롬빈의 제조방법(Process for producing thrombin)
HU9500243D0 (en) Magnetic head, magnetic head unit, as well as method of manufacturing thereof
FI971675A0 (fi) Menetelmä bradykiniinin liittyvien tilojen inhiboimiseksi
DE69320475T2 (de) Process for producing normal olefins
FI972694A (fi) Uusi menetelmä sameridiinin valmistamiseksi